Effect of Vedolizumab on Anemia of Chronic Disease in Patients with Inflammatory Bowel Diseases

Background: Anemia of Chronic Disease (ACD) can negatively influence the clinical course of Inflammatory Bowel Disease (IBD) patients. The aim of this study was to evaluate the effect of Vedolizumab on ACD in IBD. Methods: Clinical data of 75 IBD patients (25 Crohn’s disease (CD) and 50 Ulcerative C...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarozza, Patrizio, De Cristofaro, Elena, Scucchi, Ludovica, Rocchetti, Irene, Marafini, Irene, Neri, Benedetto, Salvatori, Silvia, Biancone, Livia, Calabrese, Emma, Monteleone, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408734/
https://www.ncbi.nlm.nih.gov/pubmed/32640680
http://dx.doi.org/10.3390/jcm9072126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408734/
https://www.ncbi.nlm.nih.gov/pubmed/32640680
http://dx.doi.org/10.3390/jcm9072126

Ejemplares similares